Published in Bioterrorism Week, May 4th, 2009
The underlying technology for NB-1008 is NanoBio’s NanoStatTM platform, which employs a nanoemulsion that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Bioterrorism Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.